Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Conditions

• ARFID
• Ankylosing Spondylitis (AS)
• Anorexia Nervosa
• Autoimmune Diseases
• Autoimmune Encephalitis
• Avoidant / Restrictive Food Intake Disorder
• Bulimia Nervosa
• Celiac Disease
• Celiac Disease in Children
• Chronic Lyme Disease
• Crohn's Disease
• Dysautonomia
• Ehlers Danlos Syndrome
• Endometriosis
• Fibromyalgia (FM)
• General Anxiety Disorder, Social Anxiety Disorder
• Inflammatory Bowel Disease (IBD)
• Juvenile Rheumatoid Arthritis (JRA)
• Long COVID
• Lupus
• ME/CFS
• Mast Cell Activation Syndrome
• Migraines
• Multiple Sclerosis
• Myalgic Encephalomyelitis (ME)
• Myasthenia Gravis in Children
• Myasthenia Gravis, Generalized
• Narcolepsy
• Neurological Diseases or Conditions
• Obsessive Compulsive Disorder (OCD)
• PANDAS
• POTS - Postural Orthostatic Tachycardia Syndrome
• PTSD - Post Traumatic Stress Disorder
• Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
• Post-Acute COVID-19 Syndrome
• Post-treatment Lyme Disease Syndrome
• Psoriasis
• Psoriatic Arthritis (PsA)
• Psychiatric Disorder
• Rheumatic Arthritis
• Sjogren's Syndrome
• Tourette's Syndrome
• Traumatic Brain Injury
• Ulcerative Colitis and Crohn's Disease

Eligibility Criteria

Sex

ALL

Age

2 Years - N/A

Healthy Volunteers

Accepted

Study Details

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years and older will provide self-reported health data, biometrics, and symptom diaries through the MyDataHelps™ app (branded as unhide® for this study). The goal is to create comprehensive longitudinal profiles to facilitate research into disease subtypes, causes, diagnostics, and potential treatments, as well as to identify potential participants for future optional studies. "Healthy" individuals without brain inflammation are also eligible to participate. The digital health research platform used in this study was originally developed and designed by Solve M.E and was called SolveTogether. The Brain Inflammation Collaborative (BIC) expanded upon Solve M.E.'s work to include related diagnoses, pediatric participants, enhance symptom tracking, and more. BIC and Solve M.E. combined Solve Together and unhide®, to create The unhide® Solve Together Unified Platform in 2025.

Key Dates

Start date

Jul 5, 2023

Status verified

Jan 2026

Primary completion

Jun 30, 2030

Completion

Dec 31, 2030

Study Design

Enrollment

10,000 participants (estimated)

Arms

• Arm: People with brain inflammation and related neuroinflammatory conditions
  No intervention will be administered.
• Arm: Healthy Controls
  No intervention will be administered.

Primary Outcome Measure

Phenotypic data collection [ Time Frame: From Baseline through up to 10 years, with assessments approximately every 4-12 weeks ]

Central Contacts

• Megan L Fitzgerald, PhD
  1-833-286-4433
  [email protected]
• Christina Moon
  1-833-286-4433
  [email protected]

Locations (1)

Find similar trials in Delafield, WI

Related Studies

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
  Recruiting · Center for International Blood and Marrow Transplant Research · Birmingham, Alabama
• Macromolecular Imaging of White and Gray Matter Pathology in Multiple Sclerosis
  Enrolling By Invitation · University of Wisconsin, Madison · Madison, Wisconsin
• High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
  Recruiting · Marquette University · Indianapolis, Indiana
• Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
  PHASE2 · Enrolling By Invitation · University of California, San Francisco · San Francisco, California